-
+2 +2Multiple Sclerosis Research: Listeria with Alemtuzumab - 2 cases reported
Here we report two patients treated with alemtuzumab for MS developing Listeria meningitis few days after the first infusion cycle. Both patients recovered completely after prompt diagnosis and adequate treatment. Physicians and patients should be aware of this serious, but treatable complication.
-
+12 +2The Orion Conference: Turning Big Data Into Knowledge | Multiple Sclerosis Discovery Forum
A conference in Cambridge, Massachusetts, outlined progress and challenges in turning computational modeling into actionable knowledge in MS and other brain disorders
-
+3 +2Most uses of medical marijuana wouldn't pass FDA review, study finds
Medical marijuana may improve muscle spasms in people with multiple sclerosis, study concludes.
-
+2 +2Novartis' Gilenya Found to Have Long-Term Positive Effects on Patients with Relapsing-Remitting Multiple Sclerosis
Read about the finding that fingolimod has long-term positive effects on patients with relapsing-remitting multiple sclerosis.
-
+2 +2Ilona Bidzan's multiple sclerosis documentary (Polish, captioned in English)
The 20-minute documentary was filmed in Poland and both written and directed by the psychologist Ilona Bidzan. The film is focused on the stories of the painter Emilia Ratajczak, photographer Wojciech Stańko, and dancer Gabriela Zenka. Despite the different ages and stages of life, they share a disease and a desire to change their lives, fighting the difficulties that come with an MS diagnosis.
-
+2 +2Nanometric sensor designed to detect herbicides can help diagnose multiple sclerosis
The early diagnosis of certain types of cancer, as well as nervous system diseases such as multiple sclerosis and neuromyelitis optica, may soon be facilitated by the use of a nanometric sensor capable of identifying biomarkers of these pathological conditions.
-
+3 +3Roche’s Ocrelizumab Found to be Superior to Standard Interferon Therapy in Relapsing Multiple Sclerosis Patients
Read about How Roche’s Ocrelizumab Found to be Superior to Standard Interferon Therapy in Relapsing Multiple Sclerosis Patients.
Submit a link
Start a discussion




















